CHICAGO, Aug. 9, 2018 /PRNewswire-PRWeb/ --áRiverGlade Capital ("RiverGlade"), is pleased to announce that Jim
The RiverGlade investment team has added Dan Skowronski as Vice President. Mr. Skowronski has eight years of experience investing in and advising middle market companies. Prior to joining RiverGlade, Mr. Skowronski was a Senior Associate at The Edgewater Funds and prior to that was an Associate at Swander Pace Capital. During his time at Edgewater and Swander Pace, Mr. Skowronski was involved in all aspects of each firm's investment process including deal origination and execution, debt financing and refinancing transactions, portfolio company sales, add-on acquisitions, and restructurings, as well as monitoring of portfolio companies in the healthcare, consumer and industrials sectors. Previously, he was an Investment Banking Analyst at William Blair & Company, where he executed sell-side and buy-side transactions for private equity firms, publicly-traded companies and privately-held and family-owned businesses in the consumer & retail sector. Mr. Skowronski began his career as a Financial Advisory Services Analyst at Houlihan Lokey, where he provided fairness opinions, solvency opinions and valuations for privately-held and publicly-traded companies across a variety of industries. Mr. Skowronski holds a BBA in Finance from University of Michigan's Ross School of Business and an MBA from Northwestern University's Kellogg School of Management.
About RiverGlade Capital RiverGlade Capital is a healthcare services focused private equity firm that targets founder-owned, high-quality, differentiated businesses. RiverGlade partners with companies that have proven historical organic growth where value can be accelerated through human capital investments, operational improvements, strategic planning, and dynamic organic and inorganic growth initiatives. For more information, visit http://www.rivergladecapital.com.
SOURCE RiverGlade Capital
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All